The activation of CX3CR1 activates multiple signaling pathways, in particular the Src → FAK pathway in breast cancer cells [14], lung cancer cells [16], pancreatic ductal adenocarcinoma cells [13] and in prostate cancer cells [15]. This evidence concerns the gene PTK2 and Familial prostate cancer.